2Saulsbury FT. Comparison of high - dose and low - dose aspirin plus intravenous immunoglobulin in the treatment of kawasaki syndrome [J]. Clin Pediatr (Phila) ,2002,41 (8):597 - 601. 被引量：1
3Khowsathit P, Hong- Hgam C, Khositseth A, et al. Treatment of Kawasaki disease with a moderate dose (1g/kg) of intravenous immunoglobulin[J]. J Med Assoc Thai, 2002, 85 (suppl): S1121-S1126. 被引量：1
4Terai M, Shulman ST. Prevalence of coronary artery abnormalities in kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose [J]. J Pediatr, 1997, 131 (6): 888 -893. 被引量：1
5Nishikawa M, Ichiyama T, Hasegawa M, et al. Safety from thromboembolism using intravenous immunoglobulin therapy in kawasaki disease: study of whole - blood viscosity[J]. Pediatr Int, 2003,45(2): 156- 158. 被引量：1
7Wright DA, Newburger JW, Baker A, et al. Treatment of immune globulin- resistant Kawasaki disease with pulsed doses of corticosteroids[J]. J Pediatr, 1996,128(1): 146 - 149. 被引量：1
8Sundel RP, Baker AL, Fulton DR, et al. Corticosteroids in the initial treatment of kawasaki disease: report of a randomized trial[J]. JPediatr, 2003,142 (6): 611 - 666. 被引量：1
9Lee MS, An SY, Jang GC, et al. A case of intravenous immunoglobulin resistant kawasaki disease treated with methotrexate [J ]. Yonsei Med J,2002,43 (4): 527 - 532. 被引量：1
10Hitoshi H, Toshio S, Tomoyuki M. Successful thrombolysis with intracorronary administration of tissue plasminogen activator in an infant with kawasaki disease[J]. Heart, 1997,78: 517 - 518. 被引量：1
